Navigation Links
Spaulding Clinical to Showcase First Cloud-based Cardiac Safety Solution Fully Integrated with Medidata Clinical Cloud at DIA
Date:6/12/2013

ir solutions at both the Medidata booth (#805) and Spaulding booth (#2203) at the DIA meeting, June 24-26th in Boston. Visit Spauldingclinical.com to view Spaulding’s quality metrics.

About Spaulding Clinical Research, LLC

Spaulding Clinical Research LLC, a change agent in the clinical research and medical device industries, is focused on driving perpetual value for its clients through technology and process innovation that delivers speed, unprecedented quality and lower costs.

Spaulding Clinical Research operates a 105-bed clinical pharmacology unit with 96, 12-lead ECG, telemetry beds in West Bend, Wisconsin, USA. The facility is paperless, using a customized Phase I Electronic Data Capture system with bi-directional interfaces to clinical lab, bedside devices and telemetry. Spaulding Biometrics provides full-service biostatistics, data management and medical writing services.

As a Phase I-IV centralized cardiac safety provider, Spaulding Clinical offers project management, expert cardiologist ECG over-read and a complete suite of state-of-the-art equipment provisioning, including the cloud-based Spaulding webECGTM Management Solution with the purpose-built Spaulding Model 1000iQ Electrocardiograph.

About Medidata Solutions

Medidata Solutions is the leading global provider of cloud-based solutions for clinical research in life sciences, transforming clinical development through its advanced applications and intelligent data analytics. The Medidata Clinical Cloud™ brings new levels of productivity and quality to the clinical testing of promising medical treatments, from study design and planning through execution, management and reporting. We are committed to advancing the competitive and scientific goals of global customers, which include over 90% of the top 25 global pharmaceutical companies; innovative biotech, diagnostic and device firm
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Spaulding Clinical Research Partners With Verified Clinical Trials Protecting Clinical Trials From Dual Enrollment
2. ChemoCentryx Presents Positive Results for Novel CCR2 Inhibitor in Preclinical Models of Diabetic Nephropathy at the 44th Annual Meeting of the American Society of Nephrology
3. Positive Clinical Study Results for BSPs HyperQ Technology
4. DermTechs Non-invasive Melanoma Detection Assay Poised to Enter Clinical Validation Study
5. Nile Therapeutics Announces Top-Line Results in Clinical Trial Evaluating the Subcutaneous Infusion of Cenderitide, Meets Primary Endpoint
6. AtheroNova Inc. Preclinical Study Demonstrates 95% Reduction in Arterial Plaque Formation
7. A New Type of Dendritic Cell-Based Cancer Vaccine has Received Approval for Clinical Tests and at the Same Time Secures Substantial Financing
8. Generex Provides Update on Generex Oral-lyn™ Clinical & Regulatory Program
9. US Oncology Research Affiliated Physician to Present Findings From Innovative Clinical Trial at 2011 CTRC-AACR San Antonio Breast Cancer Symposium
10. TetraLogic Pharmaceuticals Announces Initiation of a Phase 1/2 Clinical Trial of TL32711 in Patients with Acute Myelogenous Leukemia (AML)
11. Echo Therapeutics Announces Positive Results of Clinical Trial of its Symphony® Transdermal Continuous Glucose Monitoring (tCGM) System in Patients With Type 1 and Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... ANGELES , Aug. 4, 2015   California ... the recent acquisition of LifeLine Cryogenics, an east coast ... New York tristate area. LifeLine ... and all prepaid contracts will be honored. ... cryogenics services, offering storage of sperm, eggs, embryos, and ...
(Date:8/3/2015)... 3, 2015  Halozyme Therapeutics, Inc. (NASDAQ: HALO ... the second quarter 2015 on Monday, August 10, 2015 ... Torley , president and chief executive officer, will lead ... release financial results for the second quarter 2015. ... "Investors" section of Halozyme,s corporate website and a recording ...
(Date:8/3/2015)... , August 3, 2015 ... Portland Hospital waved the shortfall of ... could stand normally for the first time. ... (Photo: http://photos.prnewswire.com/prnh/20150803/254229 ) The Selective ... legs allowing him to carry out his wish to ...
(Date:8/3/2015)... London, UK (PRWEB) , ... August 03, 2015 ... ... largest consumer of benzene. Benzene is processed to get such derivatives as ethylbenzene, ... Ethylbenzene derivatives are principally used within the automotive industry for the production of ...
Breaking Biology Technology:FamilyCord Announces Acquisition of LifeLine Cryogenics 2Halozyme to Host Second Quarter 2015 Financial Results Conference Call 2Cerebral Palsy Operation by The Portland Hospital Allows a Boy to Stand Properly for the First Time 2Cerebral Palsy Operation by The Portland Hospital Allows a Boy to Stand Properly for the First Time 3World Benzene Market to Surpass 46 MMT by 2020, According to TechSci Research Report Published at MarketPublishers.com 2World Benzene Market to Surpass 46 MMT by 2020, According to TechSci Research Report Published at MarketPublishers.com 3
... 1 Baxa Corporation announces its,2008 sponsorship for ... Wheeler (founder of MicroPhage Inc.) recognized Baxa, along ... Annual All-Member,Meeting held April 29th at the University ... of the CBSA since its inception. Company founder ...
... Brian T. Griffin,group president, health plans, of Medco Health ... the Deutsche Bank 33rd Annual Health Care,Conference on May ... Boston, will begin at,10:10 a.m. ET. In addition, Medco,s ... in a panel discussion on The Future of,Personalized Medicine ...
... N.J., May 1 Osteotech, Inc.,(Nasdaq: OSTE ), ... for,regenerative healing, announced today that revenue for the first ... million for the first,quarter of 2007. Revenue from the ... segments, was $17.6 million for the three,months ended March ...
Cached Biology Technology:Baxa Announces Colorado BioScience Association Sponsorship 2Baxa Announces Colorado BioScience Association Sponsorship 3Medco to Present at the Deutsche Bank 33rd Annual Health Care Conference 2Osteotech Posts First Quarter Earnings Per Share of $.05 on Revenue Growth of 10% 2Osteotech Posts First Quarter Earnings Per Share of $.05 on Revenue Growth of 10% 3Osteotech Posts First Quarter Earnings Per Share of $.05 on Revenue Growth of 10% 4Osteotech Posts First Quarter Earnings Per Share of $.05 on Revenue Growth of 10% 5
(Date:7/27/2015)...   Zynx Health ™, the market leader ... today announced that its ZynxCarebook ™ mobile ... smartphones and tablets. With this expansion, care team ... ZynxCarebook to securely exchange messages and share assessments ... to other care settings, and improve clinical outcomes ...
(Date:7/21/2015)... , July 21, 2015 Passwords ... as seen in the recent U.S. Office of ... solution to the infosec conundrum, but developers and ... stored. To address this dilemma, Biometrics-as-a-Service provider HYPR ... Biometric Tokenization SDK for third party integration. ...
(Date:7/9/2015)... Research and Markets( ... "Biometrics for Banking; Market & Technology Analysis, ... their offering. The adoption for banking ... and the forecast is that by 2020 it ... involved in delivering biometric systems to the banking ...
Breaking Biology News(10 mins):Zynx Health Adds Android Device Support to ZynxCarebook Solution 2Zynx Health Adds Android Device Support to ZynxCarebook Solution 3HYPR Corp. Launches Industry First Biometric Tokenization Platform 2HYPR Corp. Launches Industry First Biometric Tokenization Platform 3HYPR Corp. Launches Industry First Biometric Tokenization Platform 4Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 2Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 3
... Geo-microbiologists from Arizona State University have solved a ... cyanobacteria, bore their way into limestone, sand grains, ... of carbonate. According to the lead ... the mystery of what is "at the heart ...
... Researchers from the UC Davis Health System have found ... D are significantly reduced in patients in the Sacramento ... factors that affects about one in three U.S. adults ... The study is the first to examine ...
... Spanish . One of the worst pests ... its worldwide success partly to its larvae,s nasty, sticky blood. ... and his colleagues discovered this recently, working with CABI researchers ... could lead to development of ways to overcome these defenses ...
Cached Biology News:Mystery dissolves with calcium pump discovery 2Mystery dissolves with calcium pump discovery 3Study finds low vitamin-d levels in northern California residents with metabolic syndrome 2Study finds low vitamin-d levels in northern California residents with metabolic syndrome 3Study finds low vitamin-d levels in northern California residents with metabolic syndrome 4Predatory bugs can save cornfields 2
6-carboxy-2',4,4',5',7,7'-hexachlorofluorescein, succinimidyl ester (6-HEX, SE) *single isomer*...
... Synthetic peptide derived from the C-terminal ... Specificity: Specific for the junctophilin-2 protein. ... skeletal muscle homogenates frozen mouse skeletal ... Immunohistochemistry(froz) ImmunofluorescenceStorage: Store at -20C for ...
Laminin gamma-2 (G-16)...
ABIN-2 Polyclonal Ab 100 ug rabbit polyclonal antibody. Detects ABIN-2 in human/mouse. Tested in WB....
Biology Products: